Clinical trial
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
NCT02150863 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2014
- Completion date
- April 30, 2018
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratosis, extensive photodamage, history of numerous skin cancers